Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
University of Maryland, Baltimore
National Cancer Institute (NCI)
The Cleveland Clinic
University of North Carolina, Chapel Hill
Mayo Clinic
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Stanford University
TME Pharma AG
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Mayo Clinic
Amgen
Sundsvall Hospital